Targets › ATP5F1A
1 program from 1 company in 1 trial: 1 Phase 2; Infectious disease; next expected readout Feb 2027.
Subunit alpha, of the mitochondrial membrane ATP synthase complex (F(1)F(0) ATP synthase or Complex V) that produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain (Probable). ATP synthase complex consist of a soluble F(1) head domain - the catalytic core - and a membrane F(1) domain - the membrane proton channel. (UniProt, P25705)
Open in Phaseline: the race on ATP5F1A, likelihood bands and readouts
| Company | Drug | Targets | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|---|
| Global Alliance for TB Drug Development | Bedaquiline ATP synthase inhibitor | ATP5F1A | Phase 2 | Pulmonary TB | Feb 2027 |
Pulmonary TB (1)
small molecule (1)
Global Alliance for TB Drug Development (1)
–
Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.